These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis. Yeung CK; Lam LK; Chan HH Clin Exp Dermatol; 2005 Sep; 30(5):600-2. PubMed ID: 16045716 [No Abstract] [Full Text] [Related]
28. [Lyell's syndrome in drug disease]. Sukhomlinov AB Feldsher Akush; 1982; 47(1):20-3. PubMed ID: 6916645 [No Abstract] [Full Text] [Related]
29. [Stevens-Johnson syndrome in a 3-year-old boy]. Lipińska-Piotrowska I; Kaczorowska-Hanke H; Slowińska I Wiad Lek; 1973 Jun; 26(11):1059-62. PubMed ID: 4719927 [No Abstract] [Full Text] [Related]
30. Adverse cutaneous drug eruptions and HIV: a clinician's global perspective. Todd G Dermatol Clin; 2006 Oct; 24(4):459-72, vi. PubMed ID: 17010776 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic approach to drug allergy. Harr T Chem Immunol Allergy; 2012; 97():47-60. PubMed ID: 22613853 [TBL] [Abstract][Full Text] [Related]
32. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants. Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634 [No Abstract] [Full Text] [Related]
33. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Koh MJ; Tay YK Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732 [TBL] [Abstract][Full Text] [Related]